Page 3 - Syngene International

Syngene Intl joins global consortium of healthcare groups on Covid testing

The consortium, led by Bristol Myers Squibb, will focus on a wide range of aspects from research to clinical diagnostic applications, the company said in a statement

Syngene: Investors with long term view should look at the stock on dips

While Covid-19 could is a near term opportunity, contract manufacturing is the key medium-term trigger

Syngene Int'l hits record high in a weak market, rallies 26% in two weeks

The stock rallied 6.5 per cent to Rs 596.85, surpassing its previous high Rs 594.75, touched on September 15, 2020, on the BSE.

Syngene-HiMedia's Elisa test kit for Covid-19 gets ICMR approval

The product will be launched once it receives approval from the Central Drugs Standard Control Organisation next

Syngene International rallies 13% in two days; stock nears record high

ICICI Securities expects Syngene's revenues to be back on track as the company is currently operating at 90 per cent capacity.

After a muted Q1, Syngene guides for double-digit top line growth

But ongoing capex and depreciation may weigh on bottom line

JB Chemicals & Pharma, Syngene International hit all-time highs

The stock of Syngene International has soared 24 per cent during the past month, as against a 2 per cent rise in the S&P BSE Sensex.

Syngene International gains 5% on healthy March quarter results

The company's profit after tax rose 20 per cent to Rs 120 crore relative to last year's profit of Rs 100 crore.

Syngene announces commissioning of first phase of R&D center in Hyderabad

Syngene currently operates through multiple facilities in Bengaluru spread across an area of 1.5 million square feet

Syngene appoints former Vodafone executive Sibaji Biswas as its CFO

Biswas will succeed incumbent CFO M B Chinappa, who will stay within the Biocon group of companies and join Biocon Biologics in a new role

Syngene COO Manoj Nerurkar quits, to explore start-up opportunity

The announcement of the successor will be made shortly, said the company in a regulatory filing

CEO Jonathan Hunt to join Syngene International board as whole-time director on May 1

He replaces Peter Bains, who has stepped down from company's board

Syngene International falls 5%

The company said that there was a fire last night within one of the company's laboratory building at Syngene, which has since been brought under control.

Syngene International dips over 5% after huge block deal

The stock dipped 5.5% to Rs 572 on the BSE after a more than 1% stake of the pharmaceutical company changed hands via block deal.

Syngene International hits new high on sealing deal with Strand Life Sciences

The stock rallied 9% to Rs 524, also its record high on the BSE in intra-day trade on Thursday.

Syngene International gains after starting new development center in Bangalore

The stock hit a high of Rs 494.05 and a low of Rs 477.90 so far during the day